Rykadan Capital Limited

SEHK:2288 Voorraadrapport

Marktkapitalisatie: HK$39.8m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Rykadan Capital Beheer

Beheer criteriumcontroles 2/4

De CEO Rykadan Capital's is William Chan, benoemd in Jul2012, heeft een ambtstermijn van 12.25 jaar. De totale jaarlijkse vergoeding van { bedraagt HK$ 12.98M, bestaande uit 80.7% salaris en 19.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 34.84% van de aandelen van het bedrijf, ter waarde HK$ 14.39M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.8 jaar en 11.9 jaar.

Belangrijke informatie

William Chan

Algemeen directeur

HK$13.0m

Totale compensatie

Percentage CEO-salaris80.7%
Dienstverband CEO12.3yrs
Eigendom CEO34.8%
Management gemiddelde ambtstermijn6.8yrs
Gemiddelde ambtstermijn bestuur11.9yrs

Recente managementupdates

Increases to CEO Compensation Might Be Put On Hold For Now at Rykadan Capital Limited (HKG:2288)

Sep 09
Increases to CEO Compensation Might Be Put On Hold For Now at Rykadan Capital Limited (HKG:2288)

We Discuss Why Rykadan Capital Limited's (HKG:2288) CEO Compensation May Be Closely Reviewed

Sep 13
We Discuss Why Rykadan Capital Limited's (HKG:2288) CEO Compensation May Be Closely Reviewed

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Rykadan Capital Limited (HKG:2288)

Sep 09
Increases to CEO Compensation Might Be Put On Hold For Now at Rykadan Capital Limited (HKG:2288)

Rykadan Capital Limited's (HKG:2288) 34% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jul 12
Rykadan Capital Limited's (HKG:2288) 34% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

We Discuss Why Rykadan Capital Limited's (HKG:2288) CEO Compensation May Be Closely Reviewed

Sep 13
We Discuss Why Rykadan Capital Limited's (HKG:2288) CEO Compensation May Be Closely Reviewed

Health Check: How Prudently Does Rykadan Capital (HKG:2288) Use Debt?

Jul 02
Health Check: How Prudently Does Rykadan Capital (HKG:2288) Use Debt?

Is Rykadan Capital (HKG:2288) A Risky Investment?

Mar 17
Is Rykadan Capital (HKG:2288) A Risky Investment?

Health Check: How Prudently Does Rykadan Capital (HKG:2288) Use Debt?

Jul 01
Health Check: How Prudently Does Rykadan Capital (HKG:2288) Use Debt?

Rykadan Capital (HKG:2288) Has Debt But No Earnings; Should You Worry?

Mar 07
Rykadan Capital (HKG:2288) Has Debt But No Earnings; Should You Worry?

Does Rykadan Capital (HKG:2288) Have A Healthy Balance Sheet?

Mar 16
Does Rykadan Capital (HKG:2288) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of Rykadan Capital Limited (HKG:2288)

Feb 10
Estimating The Intrinsic Value Of Rykadan Capital Limited (HKG:2288)

What Does Rykadan Capital's (HKG:2288) CEO Pay Reveal?

Jan 14
What Does Rykadan Capital's (HKG:2288) CEO Pay Reveal?

Hoi Lo Is The CFO & Company Secretary of Rykadan Capital Limited (HKG:2288) And They Just Sold 79% Of Their Shares

Dec 19
Hoi Lo Is The CFO & Company Secretary of Rykadan Capital Limited (HKG:2288) And They Just Sold 79% Of Their Shares

Is Rykadan Capital (HKG:2288) A Risky Investment?

Dec 06
Is Rykadan Capital (HKG:2288) A Risky Investment?

Analyse CEO-vergoeding

Hoe is William Chan's beloning veranderd ten opzichte van Rykadan Capital's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024HK$13mHK$10m

-HK$174m

Dec 31 2023n/an/a

-HK$186m

Sep 30 2023n/an/a

-HK$197m

Jun 30 2023n/an/a

-HK$193m

Mar 31 2023HK$12mHK$10m

-HK$189m

Dec 31 2022n/an/a

-HK$141m

Sep 30 2022n/an/a

-HK$92m

Jun 30 2022n/an/a

-HK$63m

Mar 31 2022HK$11mHK$10m

-HK$35m

Dec 31 2021n/an/a

-HK$29m

Sep 30 2021n/an/a

-HK$22m

Jun 30 2021n/an/a

-HK$9m

Mar 31 2021HK$10mHK$10m

HK$5m

Dec 31 2020n/an/a

-HK$6m

Sep 30 2020n/an/a

-HK$17m

Jun 30 2020n/an/a

-HK$47m

Mar 31 2020HK$19mHK$12m

-HK$77m

Dec 31 2019n/an/a

HK$135m

Sep 30 2019n/an/a

HK$347m

Jun 30 2019n/an/a

HK$338m

Mar 31 2019HK$20mHK$12m

HK$330m

Dec 31 2018n/an/a

HK$136m

Sep 30 2018n/an/a

-HK$58m

Jun 30 2018n/an/a

-HK$14m

Mar 31 2018HK$20mHK$12m

HK$31m

Compensatie versus markt: De totale vergoeding ($USD 1.67M ) William } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.84K ).

Compensatie versus inkomsten: De vergoeding van William is gestegen terwijl het bedrijf verliesgevend is.

CEO

William Chan (49 yo)

12.3yrs

Tenure

HK$12,978,000

Compensatie

Mr. William Chan serves as an Advisor of Yan Chai Hospital. Mr. Chan has been Chief Executive Officer of Rykadan Capital Limited since July 01, 2012. He serves as Divisional Senior Vice President of Hong K...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
William Chan
Chairman & CEO12.3yrsHK$12.98m34.84%
HK$ 13.9m
Tak Kwan Ng
Co-Founder & Non-Executive Directorno dataHK$768.00k16.79%
HK$ 6.7m
Hoi Wah Lo
CFO & Executive Director6.8yrsHK$2.87m0.017%
HK$ 6.8k
Zhuobin Leung
Director of Investments & Head of Asset Managementno datageen gegevensgeen gegevens
Benson Chan
Managing Director of Investmentno datageen gegevensgeen gegevens
Man Kit Lui
Company Secretary & Financial Controller3.3yrsgeen gegevensgeen gegevens

6.8yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2288 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.8 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
William Chan
Chairman & CEO15.4yrsHK$12.98m34.84%
HK$ 13.9m
Tak Kwan Ng
Co-Founder & Non-Executive Director9.2yrsHK$768.00k16.79%
HK$ 6.7m
Hoi Wah Lo
CFO & Executive Director3.3yrsHK$2.87m0.017%
HK$ 6.8k
King Yan To
Independent Non-Executive Director15.2yrsHK$216.00kgeen gegevens
Kwok Wah Ho
Independent Non-Executive Director14.7yrsHK$216.00kgeen gegevens
Jane Peishi Khan
Independent Non-Executive Director1.2yrsHK$113.00kgeen gegevens

11.9yrs

Gemiddelde duur

56.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2288 zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.9 jaar).